VivArt-X

Synthetic ECM

VivArt-X
Synthetic extracellular matrix platform technology

Breast cancer is one of the most common cancers in women worldwide.
After removal of tumour tissue patients typically receive a breast implant.
Current implants have a limited lifespan and carry a high risk of health
damage. A novel alternative is a fat transplant using the body’s own fat
tissue, but this is not optimal: 40 – 60% of the cells die after
transplantation due to the lack of environmental support. Therefore,
VivArt-X offers a revolutionary synthetic and biodegradable extracellular
matrix material that can provide temporary support for fat cells to grow
into healthy breast tissue. VivArt-X can offer breast cancer patients an
effective long-term solution without (multiple) intensive surgical
interventions and a faster and healthy physical and psychological recovery.

Contact

Smart Industry

Nico Nijenhuis

n.nijenhuis@novelt.com

Circular Technology

Maurits Burgering

maurits.burgering@wur.nl

MedTech

Esther Rodijk

e.rodijk@novelt.com

Privacy & Terms

Privacy Statement
Cookie Policy
General terms and conditions

Inschrijven nieuwsbrief

Meld je aan voor onze TTT nieuwsbrief.